Recon: HHS loses court case affecting 340B rebate pilot program; Eli Lilly to acquire Ventyx for nearly $1.2B
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States